The North Africa Generic drug market is currently witnessing strong growth. A generic drug is a medication with the same active ingredients as a branded drug. It is identical in terms of quality, strength, dosage, performance, and efficiency. Moreover, it offers similar therapeutic effects at a substantially low cost. Therefore, its demand is escalating in the North African region.
The burgeoning pharmaceutical industry represents one of the major factors strengthening the growth of the generic drugs market in the North African region. Moreover, governing agencies are introducing price control policies and import restrictions to encourage domestic drug manufacturing in the region. This, in turn, is strengthening the growth of the generic drugs market. Other factors adding to the generic drug market growth are the rising prevalence of non-communicable diseases and increasing healthcare costs. However, the surging cases of coronavirus disease (COVID-19) and the imposition of lockdown restrictions across the region have disrupted the production of generic drugs. This has negatively affected the market, but it is anticipated to witness growth once lockdown restrictions are uplifted in the region and the production process acquires pace. Looking forward, the market is expected to continue its strong growth during the forecast period (2021-2026).
IMARC Group provides an analysis of the key trends in each sub-segment of the North Africa Generic drug market report, along with forecasts for growth at the region level from 2021-2026. Our report has categorized the market based on region, segment, therapy area, drug delivery and distribution channel.
Breakup by Segment:
Breakup by Therapy Area:
Breakup by Drug Delivery:
Breakup by Distribution Channel:
Breakup by Country:
The competitive landscape of the industry has also been examined along with the profiles of the key players.
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at